Laurie Catley

1.9k total citations
6 papers, 223 citations indexed

About

Laurie Catley is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Laurie Catley has authored 6 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 4 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Laurie Catley's work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (2 papers). Laurie Catley is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Lymphoma Diagnosis and Treatment (2 papers). Laurie Catley collaborates with scholars based in United States, Switzerland and Australia. Laurie Catley's co-authors include Renee D. Wright, Jingrui Jiang, Daisy Moreno, Elizabeth Hall–Meyers, Ellen Weisberg, Andrew L. Kung, Arghya Ray, James D. Griffin, Paul W. Manley and Doriano Fabbro and has published in prestigious journals such as Blood, Gastroenterology and Molecular Cancer Therapeutics.

In The Last Decade

Laurie Catley

4 papers receiving 219 citations

Peers

Laurie Catley

HEMAT

MB

GENET

GASTR

PRM

Christian Hosius Germany

Firoz Ahmad India

José Antonio Queizán Spain

Yoshito Komatsu Japan

Paul Yeh Australia

Danko Martincic United States

Katy Knight United Kingdom

Juan Besalduch Spain

Kristiyana Kaneva United States

Laurie Musial United States

Christian Hosius Germany

Laurie Catley

59 ×0.6

HEMAT

84 ×1.1

MB

47 ×0.7

GENET

37 ×0.7

GASTR

54 ×1.0

PRM

Citations per year, relative to Laurie Catley Laurie Catley (= 1×) peers Christian Hosius

Countries citing papers authored by Laurie Catley

Since Specialization

Citations

This map shows the geographic impact of Laurie Catley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie Catley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie Catley more than expected).

Fields of papers citing papers by Laurie Catley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie Catley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie Catley. The network helps show where Laurie Catley may publish in the future.

Co-authorship network of co-authors of Laurie Catley

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie Catley. A scholar is included among the top collaborators of Laurie Catley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie Catley. Laurie Catley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Weisberg, Ellen, Laurie Catley, Renee D. Wright, et al.. (2016). Beneficial Effects of Combining Nilotinib and Imatinib in Preclinical Models of BCR/ABL+ Leukemias Nilotinib and Imatinib Against Bcr-Abl+ Leukemia.

2.

Weisberg, Ellen, Andrew L. Kung, Renee D. Wright, et al.. (2007). Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells. Molecular Cancer Therapeutics. 6(7). 1951–1961. 66 indexed citations

3.

Weisberg, Ellen, Renee D. Wright, Jingrui Jiang, et al.. (2006). Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib Sensitivity. Gastroenterology. 131(6). 1734–1742. 75 indexed citations

4.

Weisberg, Ellen, Laurie Catley, Renee D. Wright, et al.. (2006). Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias. Blood. 109(5). 2112–2120. 79 indexed citations

5.

Tournilhac, Olivier, Daniel Santos, Lian Xu, et al.. (2004). Constitutive Expression of CD40L on Bone Marrow Mast Cells Supports the Growth of Lymphoplasmacytic Cells in Patients with Waldenstrom’s Macroglobulinemia.. Blood. 104(11). 2350–2350. 1 indexed citations

6.

Tournilhac, Olivier, Daniel Santos, Lian Xu, et al.. (2004). Lymphoplasmacytic Cells and Mast Cells Are Targets for Imatinib Mesylate (Gleevec, Glivec) in Waldenstrom’s Macroglobulinemia.. Blood. 104(11). 4929–4929. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact